Kellie N. Smith

13.7k total citations · 1 hit paper
42 papers, 756 citations indexed

About

Kellie N. Smith is a scholar working on Oncology, Immunology and Virology. According to data from OpenAlex, Kellie N. Smith has authored 42 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Immunology and 9 papers in Virology. Recurrent topics in Kellie N. Smith's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (11 papers). Kellie N. Smith is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (14 papers) and Immune Cell Function and Interaction (11 papers). Kellie N. Smith collaborates with scholars based in United States, Lebanon and United Kingdom. Kellie N. Smith's co-authors include Drew M. Pardoll, Patrick M. Forde, Suzanne L. Topalian, Mark Yarchoan, Leisha A. Emens, Valsamo Anagnostou, Jiajia Zhang, Franck Housseau, Julie R. Brahmer and Ada Tam and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kellie N. Smith

39 papers receiving 750 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

2023 153 citations Suzanne L. Topalian, Patrick M. Forde et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kellie N. Smith United States	15	409	352	206	174	82	42	756
Melissa Zarr United States	8	230 0.6×	324 0.9×	322 1.6×	93 0.5×	27 0.3×	8	691
Jianping Yang New Zealand	20	403 1.0×	822 2.3×	256 1.2×	110 0.6×	44 0.5×	44	1.1k
Derek Ng Tang United States	10	811 2.0×	757 2.2×	281 1.4×	97 0.6×	67 0.8×	18	1.2k
Cecilia Rietz United States	9	694 1.7×	611 1.7×	178 0.9×	80 0.5×	45 0.5×	13	973
Kate Poropatich United States	12	156 0.4×	170 0.5×	125 0.6×	156 0.9×	41 0.5×	17	601
Wentao Zhang China	12	175 0.4×	260 0.7×	189 0.9×	78 0.4×	46 0.6×	33	685
JR Gralow United States	9	369 0.9×	415 1.2×	230 1.1×	98 0.6×	27 0.3×	34	796
Thi Tran France	17	452 1.1×	567 1.6×	306 1.5×	51 0.3×	25 0.3×	33	940
Magesh Sathaiah United States	11	393 1.0×	134 0.4×	159 0.8×	145 0.8×	284 3.5×	14	794
Pankita H. Pandya United States	9	145 0.4×	143 0.4×	165 0.8×	82 0.5×	20 0.2×	20	475

Countries citing papers authored by Kellie N. Smith

Since Specialization

Citations

This map shows the geographic impact of Kellie N. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie N. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie N. Smith more than expected).

Fields of papers citing papers by Kellie N. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellie N. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie N. Smith. The network helps show where Kellie N. Smith may publish in the future.

Co-authorship network of co-authors of Kellie N. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kellie N. Smith. A scholar is included among the top collaborators of Kellie N. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellie N. Smith. Kellie N. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Justin, Willemijn S.M.E. Theelen, Zineb Belcaid, et al.. (2025). Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. Nature Cancer. 6(10). 1676–1692. 5 indexed citations

Zhang, Li, et al.. (2025). The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells. Frontiers in Immunology. 16. 1513175–1513175.

Zeng, Zhen, Jiajia Zhang, Shuai Li, et al.. (2025). A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types. Nature Communications. 16(1). 1070–1070. 4 indexed citations

Hong, Xiumei, Kari C. Nadeau, Guoying Wang, et al.. (2024). Metabolomic profiles during early childhood and risk of food allergies and asthma in multiethnic children from a prospective birth cohort. Journal of Allergy and Clinical Immunology. 154(1). 168–178. 6 indexed citations

Tiniakou, Eleni, Jemima Albayda, Brittany L. Adler, et al.. (2024). Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases. 84(2). 307–318. 1 indexed citations

Pulliam, Thomas H., Lichen Jing, Heeju Ryu, et al.. (2024). Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma. Cell Reports Medicine. 5(2). 101412–101412. 15 indexed citations

Dykema, Arbor G., et al.. (2024). Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes. Cell Reports Medicine. 5(3). 101442–101442. 2 indexed citations

Rosner, Samuel, Joshua E. Reuss, Marianna Zahurak, et al.. (2023). Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(4). 705–710. 44 indexed citations

Dragoni, Filippo, Abena K. Kwaa, Rebecca T. Veenhuis, et al.. (2023). Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones. Journal of Clinical Investigation. 133(21). 7 indexed citations

10.

Voong, Khinh Ranh, Peter B. Illei, Dipika Singh, et al.. (2023). Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study. Journal for ImmunoTherapy of Cancer. 11(10). e007188–e007188. 4 indexed citations

11.

Shao, Xiaoshan M., et al.. (2023). Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity. Nature Machine Intelligence. 5(8). 861–872. 46 indexed citations

12.

Topalian, Suzanne L., Patrick M. Forde, Leisha A. Emens, et al.. (2023). Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy. Cancer Cell. 41(9). 1551–1566. 153 indexed citations breakdown →

13.

Woldemeskel, Bezawit A., et al.. (2022). CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses. Journal of Clinical Investigation. 132(5). 18 indexed citations

14.

Chan, Hok Yee, Jiajia Zhang, Caroline C. Garliss, et al.. (2020). A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants. Frontiers in Immunology. 11. 591–591. 14 indexed citations

15.

Zhang, Jiajia, Zhicheng Ji, & Kellie N. Smith. (2019). Analysis of TCR β CDR3 sequencing data for tracking anti-tumor immunity. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 443–464. 4 indexed citations

16.

Danilova, Ludmila, Valsamo Anagnostou, Justina X. Caushi, et al.. (2018). The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity. Cancer Immunology Research. 6(8). 888–899. 99 indexed citations

17.

Housseau, Franck, Shaoguang Wu, Elizabeth C. Wick, et al.. (2016). Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis. Cancer Research. 76(8). 2115–2124. 102 indexed citations

18.

Forde, Patrick M., Kellie N. Smith, Jamie E. Chaft, et al.. (2016). NSCLC, early stage Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer. Annals of Oncology. 27. vi576–vi576. 15 indexed citations

19.

Smith, Kellie N., Robbie B. Mailliard, & Charles R. Rinaldo. (2015). Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie. PubMed. 6(1-2). 67–77. 3 indexed citations

20.

Melhem, Nada M., Kellie N. Smith, Weimin Jiang, et al.. (2013). The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses. Virology. 450-451. 34–48. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact